Regulatory Exclusivity: NEW PATIENT POPULATION
✉ Email this page to a colleague
Drugs with New Patient Population Regulatory Exclusivity
Click here to exclude patents covering these drugs from this list
Applicant | Tradename | Generic Name | NDA | Approval Date | Type | Patent No. | Patent Expiration | Exclusivity Expiration | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|
Pacira Pharms Inc | EXPAREL | bupivacaine | 022496 | Oct 28, 2011 | RX | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | NEW PATIENT POPULATION |
Pacira Pharms Inc | EXPAREL | bupivacaine | 022496 | Oct 28, 2011 | RX | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | NEW PATIENT POPULATION |
Pacira Pharms Inc | EXPAREL | bupivacaine | 022496 | Oct 28, 2011 | RX | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | NEW PATIENT POPULATION |
Pacira Pharms Inc | EXPAREL | bupivacaine | 022496 | Oct 28, 2011 | RX | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | NEW PATIENT POPULATION |
>Applicant | >Tradename | >Generic Name | >NDA | >Approval Date | >Type | >Patent No. | >Patent Expiration | >Exclusivity Expiration | >Patented / Exclusive Use |